Literature DB >> 34923623

Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.

Simone Claudiani1, Jane F Apperley1, Eleanor L Parker2, Federica Marchesin2, Ksenia Katsanovskaja2, Renuka Palanicawandar1, Andrew J Innes1, Richard S Tedder2, Myra O McClure2, Dragana Milojkovic1.   

Abstract

Entities:  

Keywords:  CML; COVID-19; SARS-CoV-2; TKI; vaccines

Mesh：

Substances：

Year:  2021        PMID： 34923623     DOI： 10.1111/bjh.18001

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  [Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases in China (2022)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-05-14

2.  Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases.

Authors:  Jil Rotterdam; Margot Thiaucourt; Christel Weiss; Juliana Schwaab; Andreas Reiter; Sebastian Kreil; Laurenz Steiner; Sebastian Fenchel; Henning D Popp; Wolf-Karsten Hofmann; Karin Bonatz; Catharina Gerhards; Michael Neumaier; Stefan A Klein; Sonika Rao; Mohamad Jawhar; Susanne Saussele
Journal:  Ann Hematol       Date:  2022-05-21       Impact factor: 4.030

3.  Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.

Authors:  Sara Pasquina Pascale; Roberta Nuccorini; Teresa Pierri; Roberta Di Mare; Lucia Fabio; Emilia Lerose; Maria Antonietta Merlino; Pietro Schiavo; Angela Amendola; Gino Brucoli; Maria Denise Caputo; Ida Chitarrelli; Michele Cimminiello; Sabrina Coluzzi; Nunzio Biagio Filardi; Angela Matturro; Domenico Vertone; Monica Poggiaspalla; Francesco Malaspina; Gerardo Musuraca; Gennaro Coralluzzo; Clara Mannarella; Clelia Musto; Angela Pia Bellettieri; Giovanni Martinelli; Claudio Cerchione; Michele Pizzuti
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

4.  Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis.

Authors:  Ikhwan Rinaldi; Samuel Pratama; Lowilius Wiyono; Jeremy Rafael Tandaju; Indy Larasati Wardhana; Kevin Winston
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.